Loading...
Rimonabant: more than an anti-obesity drug?
The endocannabinoid system modulates many pathophysiological functions, including the brain pathways involved in the regulation of body weight and adipose tissue function. The selective cannabinoid CB(1) receptor antagonist, rimonabant, has undergone phase III clinical testing as anti-obesity drug....
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2007
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2189769/ https://ncbi.nlm.nih.gov/pubmed/17245359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0707139 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|